NCT06271707PHASE4Recruiting

Stellate Ganglion Block

University of Minnesota

Start Date

5/19/2025

Completion Date

7/15/2027

Summary

The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.

Eligibility Criteria

Age Range: 18 years to 85 years

Inclusion Criteria: * Patients undergoing esophagectomy, pneumonectomy, or lobectomy aged 18-85. Exclusion Criteria: * Patients who have an exclusion to regional anesthesia. * Patients who have exclusion to stellate blockade. * Patients who are pregnant assessed via self-report or pregnancy test if they have taken one

Interventions

DRUG

0.5% bupivacaine

OTHER

Saline

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

EsophagectomyPneumonectomyLobectomy

Locations

University of Minnesota

Minneapolis, Minnesota 55455

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Lay summaries for EU CTR Annex V, pre-screen filtration, recruitment-creative regulatory operations, feasibility reporting.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.